One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v126.23.2863.2863
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 5 |
Affiliation: The University of Texas MD Anderson Cancer Center, King's College London, Université Sorbonne Paris Nord, Hôpital Avicenne, Cleveland Clinic, Royal Melbourne Hospital, University Hospital Carl Gustav Carus, Klinik und Poliklinik für Psychotherapie und Psychosomatik, Heinrich Heine University Düsseldorf, University of Eastern Piedmont Amadeo Avogadro, Medical University of Warsaw, Amgen (United States), Marien Hospital Düsseldorf
Romiplostim in Thrombocytopenic Patients (Pts) with Low-Risk or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) Results in Reduced Bleeding without Impacting Leukemic Progression: Updated Follow-up Results from a Randomized, Double-Blind, Placebo (PBO)-Controlled Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
